{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:04:10Z","timestamp":1762866250832},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,10]],"date-time":"2013-09-10T00:00:00Z","timestamp":1378771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.bjid.2013.05.008","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T03:51:53Z","timestamp":1379649113000},"page":"60-64","source":"Crossref","is-referenced-by-count":5,"title":["Tuberculin skin testing in inflammatory bowel disease patients from an endemic area of Brazil"],"prefix":"10.1016","volume":"18","author":[{"given":"Ingrid Puig","family":"Cardoso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neogelia Pereira","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Rosa","family":"Gotardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Cardeal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genoile Oliveira","family":"Santana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2013.05.008_bib0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1590\/S0004-28032002000200006","article-title":"Trends in the occurrence (1980\u20131999) and clinical features of Crohn's disease and ulcerative colitis in a university hospital in southeastern Brazil","volume":"39","author":"Souza","year":"2002","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.bjid.2013.05.008_bib0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-147-10-200711200-00006","article-title":"Characteristics of spontaneous cases of tuberculosis associated with infliximab","volume":"147","author":"Raval","year":"2007","journal-title":"Ann Intern Med"},{"unstructured":"National Tuberculosis Control [Ministry of Health Web site]. July 3, 2012. Available at: http:\/\/portal.saude.gov.br\/portal\/saude\/visualizar_texto. Accessed 24.01.13.","key":"10.1016\/j.bjid.2013.05.008_bib0015"},{"key":"10.1016\/j.bjid.2013.05.008_bib0020","first-page":"168","article-title":"Tumour necrosis factor \u03b1 inhibitors: screening for tuberculosis infection in inflammatory bowel disease","volume":"188","author":"Arun","year":"2008","journal-title":"MJA"},{"key":"10.1016\/j.bjid.2013.05.008_bib0025","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1590\/S1806-37132011000300006","article-title":"Diagnosis and treatment of latent tuberculosis in patients with chronic inflammatory diseases: use of TNF-alpha-targeting biological products","volume":"37","author":"Lopes","year":"2011","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.bjid.2013.05.008_bib0030","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1590\/S1806-37132009001000011","article-title":"III Guidelines for Tuberculosis of the Brazilian Society of Thoracic","volume":"35","author":"Conde","year":"2009","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.bjid.2013.05.008_bib0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1157\/13072012","article-title":"GETECCU-2005 recommendations for the use of infliximab (Remicade) in inflammatory bowel disease","volume":"28","author":"Domenech","year":"2005","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2013.05.008_bib0040","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","author":"Solovic","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bjid.2013.05.008_bib0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1157\/13083915","article-title":"Recommendations on tuberculosis and treatment of inflammatory bowel disease with infliximab","volume":"29","author":"L\u00f3pez-San Rom\u00e1n","year":"2006","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2013.05.008_bib0050","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.cgh.2007.04.007","article-title":"Risk for active tuberculosis in inflammatory bowel disease patients","volume":"5","author":"Aberra","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2013.05.008_bib0055","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1053\/j.gastro.2009.02.036","article-title":"Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease","volume":"19","author":"Aberra","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bjid.2013.05.008_bib0060","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1155\/2007\/951526","article-title":"Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients","volume":"21","author":"Freeman","year":"2007","journal-title":"Can J Gastroenterol"},{"year":"2004","author":"Maxwell","series-title":"Designing Experiments and analyzing data: a model comparison perspective","key":"10.1016\/j.bjid.2013.05.008_bib0065"},{"key":"10.1016\/j.bjid.2013.05.008_bib0070","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ibd.20036","article-title":"Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark","volume":"13","author":"Jess","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bjid.2013.05.008_bib0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1590\/S0004-28032008000100012","article-title":"Application of the Vienna classification for Crohn's disease to a single center from Brazil","volume":"45","author":"Santana","year":"2008","journal-title":"Arq Gastroenterol"},{"unstructured":"National Tuberculosis Control [Ministry of Health Web site]. July 3, 2009. Available at: http:\/\/portal.saude.gov.br\/portal\/saude\/visualizar_texto.dtxt=28055. Accessed 7.07.09.","key":"10.1016\/j.bjid.2013.05.008_bib0080"},{"key":"10.1016\/j.bjid.2013.05.008_bib0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1590\/S0482-50042011000100004","article-title":"Low prevalence of reactive PPD prior to infliximab use: comparative study on a population sample of Hospital Geral de Fortaleza","volume":"51","author":"Callado","year":"2011","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.bjid.2013.05.008_bib0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1542-3565(04)00060-6","article-title":"High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before Infliximab therapy","volume":"2","author":"Mow","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2013.05.008_bib0095","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.MIB.0000160742.91602.b7","article-title":"Methods to avoid infections in patients with inflammatory bowel disease","volume":"11","author":"Aberra","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bjid.2013.05.008_bib0100","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3748\/wjg.14.4280","article-title":"Role of cytokines in inflammatory bowel disease","volume":"14","author":"Sanchez-Munoz","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bjid.2013.05.008_bib0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2036.2007.03553.x","article-title":"Review article: minimizing tuberculosis during anti-tumors necroses factor alpha treatment of inflammatory bowel disease","volume":"27","author":"Their","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bjid.2013.05.008_bib0110","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","article-title":"Risk of tuberculosis in patients treated with TNF antagonists due to incomplete prevention of reactivation of latent infection","volume":"57","author":"Gomez-Reino","year":"2007","journal-title":"Arthritis Rheumat"},{"key":"10.1016\/j.bjid.2013.05.008_bib0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/S0303-76572008000100008","article-title":"Booster effect on tuberculin skin tests at a university hospital in Mato Grosso do Sul","volume":"33","author":"Oliveira","year":"2008","journal-title":"Rev Bras Sa\u00fade Ocup"},{"key":"10.1016\/j.bjid.2013.05.008_bib0120","first-page":"11","article-title":"Rheumatoid arthritis: immunosupressive trials and tuberculosis","volume":"43","author":"Mangini","year":"2003","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.bjid.2013.05.008_bib0125","first-page":"15","article-title":"Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection","volume":"31","author":"Mazurek","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.bjid.2013.05.008_bib0130","first-page":"2799","article-title":"Comparison of interferon-gamma release assay versus tuberculin test for tuberculosis screening in inflammatory bowel disease","volume":"103","author":"Schoepfer","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.bjid.2013.05.008_bib0135","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/ibd.22901","article-title":"Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"18","author":"Shahidi","year":"2012","journal-title":"Inflamm Bowel Dis"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867013002031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867013002031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:25:17Z","timestamp":1715991917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867013002031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1413867013002031"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2013.05.008","relation":{},"ISSN":["1413-8670"],"issn-type":[{"type":"print","value":"1413-8670"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}